Global Rotating Gamma System (RGS) Market Strategic Research Report

Scope of the Report

The global Rotating Gamma System (RGS) market size is predicted to grow from US$ 177 million in 2025 to US$ 239 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032.

A Rotating Gamma System (RGS) is a cobalt-60 (⁶⁰Co)–based stereotactic radiosurgery / stereotactic radiotherapy platform that concentrates many narrowly collimated gamma beams onto a defined isocenter to deliver a very high, conformal dose to a small target (most commonly intracranial).

The upstream supply chain centers on: sealed ⁶⁰Co sources (radioisotope production, encapsulation, transport, loading/reloading services), heavy radiation shielding and collimation hardware (commonly high-density materials such as tungsten in gamma radiosurgery collimator assemblies), precision electromechanical rotation/gantry & couch systems, and the treatment planning + dosimetry/QA ecosystem (commissioning phantoms, chambers/film, routine verification). Modern stereotactic programs also depend on 3D imaging (CT/MRI/PET), image guidance, and immobilization/positioning systems to keep geometric errors extremely small.

Downstream, RGS is deployed in hospital radiation oncology / neurosurgery programs as a non-incisional, high-precision modality for selected lesions where steep dose fall-off is needed. Clinically it is used in the same stereotactic framework as other radiosurgery platforms: target definition by CT/MRI, immobilization, plan optimization, and delivery in single-fraction SRS or hypofractionated stereotactic radiotherapy when clinically indicated.

In 2025, global sales of Rotating Gamma System (RGS) reached approximately 52 units, with an average global market price of around US$ 3.5 million/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 35% to 45%.

Demand for rotating gamma and dedicated gamma radiosurgery platforms is anchored in their clinical value: highly conformal dose delivery, steep dose fall-off, and a minimally invasive workflow that can be completed efficiently for carefully selected intracranial lesions and certain functional indications. As multidisciplinary oncology pathways mature and patients place greater weight on recovery time and quality of life, hospitals with strong neuro-oncology capability continue to view dedicated stereotactic platforms as a way to differentiate clinical outcomes and streamline care. Technology refreshes that improve planning efficiency, image registration, and workflow automation further encourage existing centers to upgrade rather than stand still.

The market’s main constraints are concentrated in capital intensity and regulatory complexity. Site shielding and commissioning, radioactive source logistics, licensing, and radiation safety governance all add friction and extend decision cycles. In parallel, ongoing advances in linac-based stereotactic solutions intensify competition by offering broader versatility and resource sharing across departments, pushing gamma platforms toward a “high-specialization, high-utilization” positioning where operational excellence and referral networks matter as much as the equipment itself.

Overall, the segment behaves like an installed-base business: recurring service, software, and source-replacement activities are material to lifecycle economics, and leading suppliers reinforce loyalty through clinical evidence, training ecosystems, and end-to-end uptime support. Future expansion is therefore more sensitive to neuro-oncology capacity building and the sustained recognition of stereotactic value than to simple equipment proliferation.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rotating Gamma System (RGS) market?

What factors are driving Rotating Gamma System (RGS) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rotating Gamma System (RGS) market opportunities vary by end market size?

How does Rotating Gamma System (RGS) break out by Type, by Application?

This report presents a comprehensive overview of the global Rotating Gamma System (RGS) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Head Gamma Knife
• Body Gamma Knife

Segment by Source Motion Mode

• Rotating-Source Gamma System
• Static-Source Gamma System

Segment by Collimation Architecture

• Fixed Cone Collimators
• Helmet-Based Interchangeable Collimation
• Other

Segment by Application

• Brain Stereotactic Radiosurgery
• Stereotactic Body Radiation Therapy (SBRT)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Rotating Gamma System (RGS) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Brain Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy (SBRT) evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact